Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway

Published:2016-12 Issue: Volume:193 Page:538-545
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Liu Xia,Xiao Xiang-yang,Shou Qi-yang,Yan Jun-feng,Chen Long,Fu Hui-ying,Wang Jian-chao

Funder

Province Natural Science Foundation of Zhejiang

the Health and Family Planning Commission Science Foundation of Zhejiang

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference37 articles.

1. Role of NF-kappaB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death;Arlt;Oncogene,2003

2. Vinflunine: a new microtubule inhibitor agent;Bennouna;Clin. Cancer Res,2008

3. Myc and cell cycle control;Bretones;Biochim. Biophys. Acta,2015

4. Current treatment options for pancreatic carcinoma;Castellanos;Curr. Oncol. Rep.,2011

5. Pancreatic cancer genomics;Chang;Curr. Opin. Genet. Dev.,2014

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HTB50-2 Inhibits Growth and Migration of Triple-negative Breast Cancer via FOSL2/FOXC1 Signaling Axis and Subsequent Ferroptosis;Current Medicinal Chemistry;2024-08-09

2. Bufalin Suppresses Head and Neck Cancer Development by Modulating Immune Responses and Targeting the β-Catenin Signaling Pathway;Cancers;2024-08-01

3. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives;Frontiers in Pharmacology;2023-10-04

4. Advances in the treatment of pancreatic cancer with traditional Chinese medicine;Frontiers in Pharmacology;2023-08-07

5. Toad venom bufadienolides and bufotoxins: An updated review;Drug Development Research;2023-05-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3